What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Asthma
His primary areas of study are Asthma, Pediatrics, Allergy, Immunology and Allergen.
His Asthma research includes themes of Adverse effect, Disease and Atopic dermatitis.
His Pediatrics research is multidisciplinary, incorporating elements of Wheeze, Odds ratio, Airborne allergen and Cohort study.
His Allergy research incorporates elements of Internal medicine and Immunopathology.
He is studying Immunoglobulin E, which is a component of Immunology.
The Allergen study combines topics in areas such as Sensitization and Histamine.
His most cited work include:
- Atopy in children of families with an anthroposophic lifestyle (484 citations)
- Breast-feeding reduces the risk of asthma during the first 4 years of life (241 citations)
- Early BCG vaccination and development of atopy (238 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Immunology, Allergy, Immunoglobulin E, Allergen and Pediatrics.
Immunology and Virology are commonly linked in his work.
His Allergy research is multidisciplinary, relying on both Dermatology, Prospective cohort study, Asthma and Immunopathology.
Gunnar Lilja combines subjects such as Food allergy, Internal medicine and Antigen with his study of Immunoglobulin E.
His work in Allergen covers topics such as Omalizumab which are related to areas like Clinical trial.
His research in Pediatrics intersects with topics in Anaphylaxis, Disease, Incidence and Cohort.
He most often published in these fields:
- Immunology (71.52%)
- Allergy (53.16%)
- Immunoglobulin E (56.33%)
What were the highlights of his more recent work (between 2016-2021)?
- Immunology (71.52%)
- Allergen (42.41%)
- Pediatrics (44.94%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Immunology, Allergen, Pediatrics, Allergy and Immunoglobulin E.
His Allergen study combines topics from a wide range of disciplines, such as Food allergy, Omalizumab and Basophil.
His studies examine the connections between Pediatrics and genetics, as well as such issues in Disease, with regards to Prospective cohort study and Logistic regression.
He works on Allergy which deals in particular with Dog dander.
His studies in Immunoglobulin E integrate themes in fields like Internal medicine and Sensitization.
His Sensitization study incorporates themes from Asymptomatic, Asthma and Clinical significance.
Between 2016 and 2021, his most popular works were:
- Individually dosed omalizumab: an effective treatment for severe peanut allergy (31 citations)
- Individually dosed omalizumab: an effective treatment for severe peanut allergy (31 citations)
- Molecular allergy diagnostics refine characterization of children sensitized to dog dander. (21 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Asthma
Gunnar Lilja mainly investigates Internal medicine, Immunoglobulin E, Allergen, Food allergy and Omalizumab.
The Immunoglobulin E study combines topics in areas such as Gastroenterology, Asthma, Allergy and Sensitization.
Particularly relevant to Peanut allergy is his body of work in Allergy.
His study in Sensitization is interdisciplinary in nature, drawing from both Odds ratio, Inflammatory biomarkers, Nasal provocation test, Airway and Risk factor.
He focuses mostly in the field of Airway, narrowing it down to matters related to FEV1/FVC ratio and, in some cases, Pediatrics, Pulmonary function testing, Respiratory distress, Plethysmograph and Airway obstruction.
His Food allergy research incorporates elements of Clinical trial, Adverse effect, Anaphylaxis, Allergen immunotherapy and Maintenance dose.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
